Vor Biopharma Inc. held a special meeting of stockholders on August 25, 2025. During the meeting, stockholders approved the issuance of shares of Common Stock underlying outstanding warrants. Additionally, an amendment and restatement of the 2021 Equity Incentive Plan was approved.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vor Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-189169), on August 27, 2025, and is solely responsible for the information contained therein.